Regeneron Pharmaceuticals (REGN) Exchange Rate Effect (2023 - 2026)
Regeneron Pharmaceuticals' (REGN) quarterly Exchange Rate Effect came in at -$900000.0 in Q1 2026, down 250.0% year-on-year from $600000.0 in Q1 2025, and down 200.0% quarter-over-quarter from -$300000.0 in Q4 2025.
Regeneron Pharmaceuticals (REGN) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Regeneron Pharmaceuticals' Exchange Rate Effect history runs 4 years deep, the most recent figure standing at -$900000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 250.0% year-over-year to -$900000.0 in Q1 2026; TTM through Mar 2026 was -$1.2 million, a 400.0% decrease from a year earlier, with the FY2025 full-year figure at $300000.0, up 142.86% from the prior year.
- Exchange Rate Effect fell to -$900000.0 in Q1 2026 per REGN's latest filing, from -$300000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $800000.0 in Q3 2024 and bottomed at -$900000.0 in Q1 2026.
- The 4-year median for Exchange Rate Effect is -$300000.0 (2024), against an average of -$141666.7.
- Biggest YoY gain for Exchange Rate Effect was 500.0% in 2024; the steepest drop was 450.0% in 2024.
- Year by year, Exchange Rate Effect stood at $200000.0 in 2023, then sank by 450.0% to -$700000.0 in 2024, then surged by 57.14% to -$300000.0 in 2025, then sank by 200.0% to -$900000.0 in 2026.
- Per Business Quant, the three latest REGN Exchange Rate Effect figures stand at -$900000.0 (Q1 2026), -$300000.0 (Q4 2025), and -$400000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | -7.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -900,000.00 |
| Mar 31, 2026 | -900,000.00 |
| Dec 31, 2025 | -300,000.00 |
| Dec 31, 2025 | -300,000.00 |
| Sep 30, 2025 | -400,000.00 |
| Sep 30, 2025 | -400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | -700,000.00 |
| Dec 31, 2024 | -700,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | -300,000.00 |
| Jun 30, 2024 | -300,000.00 |
| Mar 31, 2024 | -500,000.00 |
| Mar 31, 2024 | -500,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |